Jane Rhodes

Jane Rhodes is the President & Chief Business Officer at Verge Genomics, Chairperson at Pheno Therapeutics Ltd, and a Co-Founder & Board Observer at Qr8 Health. With experience in various roles at companies like Turbine, FORMA Therapeutics, Biogen, and Eisai US, Jane has a strong background in neuropharmacology and business development. Jane's educational background includes a PhD in Neuropharmacology from The University of Manchester and an MBA from Babson F.W. Olin Graduate School of Business.